|Day Low/High||1.65 / 1.84|
|52 Wk Low/High||1.20 / 6.24|
Presentation will highlight additional analyses of the CHABLIS-SC1, Phase 3 clinical study of blisibimod
Presentation to highlight data from the CHABLIS-SC1, Phase 3 clinical study of blisibimod
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.